Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic...

σε πρόσθεσε στο άλλο

2026-06-17 05:24:36 -

Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease Treatment

According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...

0 Σχόλια 0 Μοιράστηκε 18 Views 0 Προεπισκόπηση